Patrick G Pilié

7PUBLICATIONS
114CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 29, 2024
A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration-Resistant Prostate Cancer.

Ana M Aparicio, Rebecca S S Tidwell, Shalini S Yadav

|Feb 28, 2024
Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types.

Patrick G Pilié, Virginia Giuliani, Wei-Lien Wang

|Aug 15, 2023
SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth Suppression.

Chuandong Geng, Man-Chao Zhang, Ganiraju C Manyam

|Aug 01, 2023
SETD2 Loss and ATR Inhibition Synergize to Promote cGAS Signaling and Immunotherapy Response in Renal Cell Carcinoma.

Xian-De Liu, Yan-Ting Zhang, Daniel J McGrail

|Apr 12, 2022
Precision Combination Therapies Based on Recurrent Oncogenic Coalterations.

Xubin Li, Elisabeth K Dowling, Gonghong Yan

|Jun 25, 2021
ATR Inhibition Induces CDK1-SPOP Signaling and Enhances Anti-PD-L1 Cytotoxicity in Prostate Cancer.

Zhe Tang, Patrick G Pilié, Chuandong Geng

Pageof 2